<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D0C641B-A9FD-4C32-8357-E66C0F8A9AF2"><gtr:id>9D0C641B-A9FD-4C32-8357-E66C0F8A9AF2</gtr:id><gtr:firstName>Gonzalo</gtr:firstName><gtr:surname>Blanco</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U142684168"><gtr:id>2E9404D3-9A5F-4FA0-981E-E9669E40594B</gtr:id><gtr:title>Mouse Neuromuscular Genetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U142684168</gtr:grantReference><gtr:abstractText>Understanding muscle hypertrophy will eventually permit us to modulate it pharmacologically and this will have broad implications because muscle atrophy is a common feature of many neuromuscular disorders and unrelated conditions such as AIDS, sepsis, persistent diabetes or long periods of inactivity. Muscle atrophy is a common denominator in all of our neuromuscular mutants, but this feature is particularly relevant in the ky mouse. We have shown that this mutant lacks a normal hypertrophic response to chronic overload, identified the causative mutation in a novel protein named KY and provided evidence that titin associated proteins putatively involved in sensing stretch were upregulated in mutant muscles. We hypothesize that novel players of the hypertrophic process may be revealed by disentangling the KY protein complex. We are currently addressing the hypothesis that IGFN1, a KY interacting partner, is a muscle hypertrophy player through the generation of a mouse conditional KO.</gtr:abstractText><gtr:technicalSummary>Our continuous goal has been to exploit mouse genetics to identify novel muscle proteins with a crucial role in muscle function. Our current projects currently encompass mechanisms of muscle hypertrophy/atrophy, muscle disease and neuromuscular homeostasis, respectively derived from the analysis of the mouse mutants ky, ariel and ostes. Past work has focused on the classical ky-kyphoscoliosis neuromuscular mutant, which bears a mutation in the ky gene and suffers from a muscle hypertrophy deficiency. Recently, we were able to demonstrate that the KY protein is a Z-band protein and that in ky/ky muscles there is a total absence of KY protein. On the other hand, histopathology of ariel showed the presence of large protein aggregates and myofibrillar degeneration in skeletal muscle. We have identified the mutation in ariel in the gene Myh4, within the motor domain of the myosin MyHC IIb. Our aim now is to validate ariel as a pre-clinical model for testing agents aimed at resolving or preventing protein aggregate formation. Finally, characterization of ostes has demonstrated the implication of the TRPP channel PKD1L2 in neuromuscular homeostasis, a work that was featured in the cover of the journal Human Molecular Genetics in Oct 2009.|</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1820186</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences</gtr:department><gtr:description>Identification of neuro protective genetic factors by endoconfocal microscopy</gtr:description><gtr:id>4A405753-2889-4A94-A38A-8772A061C2FE</gtr:id><gtr:impact>The following paper has been accepted for publication: Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy. Wong F, Fan L, Wells S, Hartley R, Mackenzie FE, Oyebode O, Brown R, Thomson D, Coleman MP, Blanco G, Ribchester RR. Mol Cell Neurosci. 2009 Aug 14. [Epub ahead of print] PMID: 19683573</gtr:impact><gtr:outcomeId>08DD23AD888-1</gtr:outcomeId><gtr:partnerContribution>As part of a collaborative MRC pathfinder project led by Prof. Richard Ribchester (University of Edinburgh) that includes myself as co-applicant, a unique neuromuscular phenotyping platform was implemented and has now been established at Harwell. The aim of this effort was to identify genetic enhancers of synaptic protection. Our method is based upon high-throughput real time fluorescence confocal microendoscopic imaging (f-CoMe) of ENU mutagenized Thy1.2-YFP16 transgenic mice that express yellow fluorescent protein in motoneurons. This project has been completed and the results publilshed.</gtr:partnerContribution><gtr:piContribution>Supervision of mouse colonies and genetic crosses. Supervision of postdoc running the project at Harwell. Co-writer of the published paper.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Platform presentation at Woods Hole</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2BA9C2FE-F950-47F1-98C2-1EF2898A670F</gtr:id><gtr:impact>Platform presentation at the Muscle in Health and Disease symposium Sept 9-13, organized by Society of General Physiologists, in Woods Hole, MA, USA

Dissemination of our research at an International meeting</gtr:impact><gtr:outcomeId>021076C14B0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral platform presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2AFD51B6-2F1C-4C47-B7BD-829F77DDE338</gtr:id><gtr:impact>Presentation on the identification of a novel TRPP channel involved in neuromuscular homeostasis at the 18th International Symposium on ALS/MND in Toronto, Canada.

The findings described in this presentation were included amongst the scientific highlights of the conference.</gtr:impact><gtr:outcomeId>DA352A068BB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Andalusian Centre for Regenerative Medicine (CABIMER)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8033F299-2DFA-466A-99E3-6D4B84125620</gtr:id><gtr:impact>Invited lecture, Andalusian Centre for Regenerative Medicine (CABIMER), Seville

Disemination of our research</gtr:impact><gtr:outcomeId>6B05252FADB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centro de Investigaciones Biol?gicas, Madrid</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7C61C428-58D8-4833-98D7-0A22CAAFDDE1</gtr:id><gtr:impact>Invited lecturer, Centro de Investigaciones Biol&amp;oacute;gicas, Madrid

Dissemination of our research activities</gtr:impact><gtr:outcomeId>B418FAB9CC3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>5015C842-FCE9-4B99-B626-B20A117F6DC3</gtr:id><gtr:outcomeId>J5bD4HizgU40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Research Grant</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>34445AF1-02D5-46B7-8986-2F0E551B40B2</gtr:id><gtr:outcomeId>3FC2D0960BD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Genetics Society</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>The Genetics Society</gtr:fundingOrg><gtr:id>59F70639-0C81-4011-A166-51FF836D3357</gtr:id><gtr:outcomeId>DqFJ1Ph2uv80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A new myoblast cell line has been developed by RNA interference that expresses the protein Igfn1_v2 at lower levels. This cell line is useful resource to study the mechanisms of myoblast fusion in mammals and will be made available to the scientific community following peer review publication.</gtr:description><gtr:id>52551F34-AAD0-45B7-B943-D272F521C31C</gtr:id><gtr:impact>This cell line has enabled us to establish that IGFN1_v2 is a cytoskeletal component essential for myoblast fusion. In its absence, myoblast fusion does not occur while myogenesis proceeds normally within single cells.</gtr:impact><gtr:outcomeId>54E404A9BE5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A knock-down C2C12 cell line in the gene Igfn1</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>823AA4A5-B103-44BE-80BD-E639485E29F6</gtr:id><gtr:title>Proteomic analysis of laser capture microscopy purified myotendinous junction regions from muscle sections.</gtr:title><gtr:parentPublicationTitle>Proteome science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b496cdae2a8d870f7a126eb8a2b1763"><gtr:id>7b496cdae2a8d870f7a126eb8a2b1763</gtr:id><gtr:otherNames>Can T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-5956</gtr:issn><gtr:outcomeId>5460bba17c3492.69652953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84F3313B-59BC-4017-9CBB-070595814677</gtr:id><gtr:title>Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0206801693adaffd3a4a6612f510714f"><gtr:id>0206801693adaffd3a4a6612f510714f</gtr:id><gtr:otherNames>Beatham J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>D9CA74F6506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F183E9-A479-4853-8224-1F703FD5DE38</gtr:id><gtr:title>The fraction of strongly bound cross-bridges is increased in mice that carry the myopathy-linked myosin heavy chain mutation MYH4L342Q.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/397dfdc7a00b0151365bdb01d76f3af4"><gtr:id>397dfdc7a00b0151365bdb01d76f3af4</gtr:id><gtr:otherNames>Lindqvist J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_14914_24_23335206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BADF6AFA-D07E-4CD7-8213-B2C5FA181783</gtr:id><gtr:title>Constitutive upregulations of titin-based signalling proteins in KY deficient muscles.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0206801693adaffd3a4a6612f510714f"><gtr:id>0206801693adaffd3a4a6612f510714f</gtr:id><gtr:otherNames>Beatham J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>E70968E3D9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F08D62-3A95-410D-A1D5-5890B12D1BC7</gtr:id><gtr:title>Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/470ac557005194651f04e8c18cb3486f"><gtr:id>470ac557005194651f04e8c18cb3486f</gtr:id><gtr:otherNames>Wong F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>A39C3497088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF654A8B-A5CD-4301-889F-F378F2D18E5A</gtr:id><gtr:title>Myofibrillar myopathy caused by a mutation in the motor domain of mouse MyHC IIb.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae282c81a81f5675529bc5f4f9a7c781"><gtr:id>ae282c81a81f5675529bc5f4f9a7c781</gtr:id><gtr:otherNames>Kurapati R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14914_24_22199023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD5D11BC-4F9C-4CEE-B30B-E24363D39103</gtr:id><gtr:title>Reaching and grasping phenotypes in the mouse (Mus musculus): a characterization of inbred strains and mutant lines.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fcb2c2c9a600a81c8b23c0c3d9008c9"><gtr:id>5fcb2c2c9a600a81c8b23c0c3d9008c9</gtr:id><gtr:otherNames>Tucci V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>F4355D0C48B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13347780-ECD7-4B2E-8383-A35CE42A0AF4</gtr:id><gtr:title>Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22531b9cd6444b8fbcae32050fb34a54"><gtr:id>22531b9cd6444b8fbcae32050fb34a54</gtr:id><gtr:otherNames>Mackenzie FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>C9D3EA6B8A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>730FBFDF-C993-4990-BAE1-A4E9D715E637</gtr:id><gtr:title>A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311b04aa4c17b316103c9775174f68e9"><gtr:id>311b04aa4c17b316103c9775174f68e9</gtr:id><gtr:otherNames>Ricketts T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460bba1d917a8.60838584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74A9296E-C75B-4470-A607-32702F3608A1</gtr:id><gtr:title>Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae312a95b658688d9e502f838b047b75"><gtr:id>ae312a95b658688d9e502f838b047b75</gtr:id><gtr:otherNames>Corrochano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5460bba1a22104.36339136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>782043F2-EF01-4F2B-AC69-52DCD0072E37</gtr:id><gtr:title>IGFN1_v1 is required for myoblast fusion and differentiation</gtr:title><gtr:parentPublicationTitle>PLOS ONE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6718f6eccd425b600bbd5ed15d4239cf"><gtr:id>6718f6eccd425b600bbd5ed15d4239cf</gtr:id><gtr:otherNames>Li Xiang</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a35133a6d5124.03812754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B127AE-AC62-41DF-8053-E8CCFDCCD313</gtr:id><gtr:title>Identification of a Z-band associated protein complex involving KY, FLNC and IGFN1.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/672b6dd5f694861084a9b8221492beab"><gtr:id>672b6dd5f694861084a9b8221492beab</gtr:id><gtr:otherNames>Baker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>G8RwvDkjrZ7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U142684168</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>